{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:17:09Z","timestamp":1793661429180,"version":"4.5.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02331-5","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T10:55:15Z","timestamp":1646391315000},"page":"201-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Oral minoxidil use in androgenetic alopecia and telogen effluvium"],"prefix":"10.1007","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4146-4747","authenticated-orcid":false,"given":"Brittany","family":"Feaster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toluwalashe","family":"Onamusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry E.","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"McMichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"issue":"1","key":"2331_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jdv.14624","volume":"32","author":"V Kanti","year":"2018","unstructured":"Kanti V, Messenger A, Dobos G et al (2018) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men\u2014short version. J Eur Acad Dermatol Venereol 32(1):11\u201322","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"2331_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/14740338.2018.1533549","volume":"17","author":"HM Almohanna","year":"2018","unstructured":"Almohanna HM, Perper M, Tosti A (2018) Safety concerns when using novel medications to treat alopecia. Expert Opin Drug Saf 17(11):1115\u20131128","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"2331_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40257-014-0077-5","volume":"15","author":"S Varothai","year":"2014","unstructured":"Varothai S, Bergfeld WF (2014) Androgenetic alopecia: an evidence-based treatment update. Am J Clin Dermatol 15(3):217-230.8","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"2331_CR4","doi-asserted-by":"publisher","first-page":"AB113","DOI":"10.1016\/j.jaad.2015.02.466","volume":"72","author":"RP Saoraya Lueangarun","year":"2015","unstructured":"Saoraya Lueangarun RP, Tempark T, Noppakun N (2015) Efficacy and safety of oral minoxidil 5 mg daily during 24\u00a0week treatment in male androgenetic alopecia. J Am Acad Dermatol 72(5):AB113","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2331_CR5","doi-asserted-by":"publisher","first-page":"e14234","DOI":"10.1111\/dth.14234","volume":"33","author":"M Vastarella","year":"2020","unstructured":"Vastarella M, Cantelli M, Patr\u00ec A, Annunziata MC, Nappa P, Fabbrocini G (2020) Efficacy and safety of oral minoxidil in female androgenetic alopecia. Dermatol Ther 33(6):e14234. https:\/\/doi.org\/10.1111\/dth.14234 (Epub 2020 Sep 14)","journal-title":"Dermatol Ther"},{"issue":"5","key":"2331_CR6","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jaad.2020.05.129","volume":"83","author":"AK Jha","year":"2020","unstructured":"Jha AK, Sonthalia S, Zeeshan MD, Vinay K (2020) Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia. J Am Acad Dermatol 83(5):1491\u20131493. https:\/\/doi.org\/10.1016\/j.jaad.2020.05.129 (Epub 2020 May 31)","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2331_CR7","doi-asserted-by":"publisher","first-page":"e12707","DOI":"10.1111\/dth.12707","volume":"31","author":"RA Beach","year":"2018","unstructured":"Beach RA (2018) Case series of oral minoxidil for androgenetic and traction alopecia: tolerability & the five C\u2019s of oral therapy. Dermatol Ther 31(6):e12707","journal-title":"Dermatol Ther"},{"issue":"1","key":"2331_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/ijd.13838","volume":"57","author":"RD Sinclair","year":"2018","unstructured":"Sinclair RD (2018) Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Int J Dermatol 57(1):104\u2013109","journal-title":"Int J Dermatol"},{"issue":"3","key":"2331_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jaad.2020.10.032","volume":"84","author":"RA Beach","year":"2021","unstructured":"Beach RA, McDonald KA, Muylaert BB (2021) Low-dose oral minoxidil for treating alopecia: a 3\u00a0year North American retrospective case series. J Am Acad Dermatol 84(3):761\u2013763. https:\/\/doi.org\/10.1016\/j.jaad.2020.10.032 (Epub 2020 Oct 22)","journal-title":"J Am Acad Dermatol"},{"key":"2331_CR10","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.12688\/f1000research.11775.1","volume":"6","author":"E Perera","year":"2017","unstructured":"Perera E, Sinclair R (2017) Treatment of chronic telogen effluvium with oral minoxidil: a retrospective study. F1000Res 6:1650","journal-title":"F1000Res"},{"issue":"6","key":"2331_CR11","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.jaad.2021.02.054","volume":"84","author":"S Va\u00f1\u00f3-Galv\u00e1n","year":"2021","unstructured":"Va\u00f1\u00f3-Galv\u00e1n S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones \u00d3M, Saceda-Corralo D, Rodrigues-Barata R, Jimenez-Cauhe J, Koh WL, Poa JE, Jerjen R, Trindade de Carvalho L, John JM, Salas-Callo CI, Vincenzi C, Yin L, Lo-Sicco K, Waskiel-Burnat A, Starace M, Zamorano JL, Ja\u00e9n-Olasolo P, Piraccini BM, Rudnicka L, Shapiro J, Tosti A, Sinclair R, Bhoyrul B (2021) Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol 84(6):1644\u20131651. https:\/\/doi.org\/10.1016\/j.jaad.2021.02.054 (Epub 2021 Feb 24)","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2331_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaad.2019.08.060","volume":"82","author":"PM Ramos","year":"2020","unstructured":"Ramos PM, Sinclair RD, Kasprzak M, Miot HA (2020) Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial. J Am Acad Dermatol 82(1):252\u2013253. https:\/\/doi.org\/10.1016\/j.jaad.2019.08.060 (Epub 2019 Aug 29)","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2331_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.jaad.2020.11.035","volume":"84","author":"B Sanabria","year":"2021","unstructured":"Sanabria B, Vanzela TN, Miot HA, M\u00fcller RP (2021) Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients. J Am Acad Dermatol 84(4):1175\u20131178. https:\/\/doi.org\/10.1016\/j.jaad.2020.11.035 (Epub 2020 Nov 27)","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02331-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T17:27:54Z","timestamp":1676827674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02331-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["2331"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02331-5","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"10 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Reviewed and approved by Wake IRB, approval #57830.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}}]}}